Newsroom

Celdara Announces DRIVEN Fund Awardees

October 21, 2021 Celdara Medical

Celdara Medical, LLC today announced the awarding of six DRIVEN Accelerator Hub grants to outstanding researchers and innovators in the Northeast region. In this most recent round of funding, two Acceleration Awards (up to $50,000 per early-stage company) were awarded to Olfax Medical (Vermont) and ResusciTech (Rhode Island) and 4 Ignition Awards (up to $25,000 per faculty innovator) were awarded to Andre Khalil, PhD (University of Maine), Gian Ignacio, MD Candidate (Brown), Michael Cole, PhD (Dartmouth), and Yina Huang, PhD (Dartmouth).

Celdara Medical Names Entrepreneur Fellows

October 5, 2021 Celdara Medical

Celdara Medical, LLC today announced the selection of five outstanding researchers as the recipients of the 2021 Celdara Medical High-Potential Entrepreneurs’ Fellowships (CHEF). The program provides a part-time, year-long experiential learning opportunity at Celdara to senior graduate students and post-doctoral researchers. Fellows receive an opportunity to hone their executive skills […]

Employee Spotlight: Joana Murad Mabaera PhD

September 27, 2021 Celdara Medical

Joana Murad Mabaera, Executive Director of R&D Expertise: Cellular Therapies and Molecular Biomarkers What are your professional interests & in what ways does Celdara help you engage those interests? My core professional interest is translational science. At Celdara Medical, I help build the foundation for the development of […]

Immutype: Providing Clarity in Complex Autoimmune Diseases

September 22, 2021 Celdara Medical

ImmuType™ is a Celdara Medical Enterprise focused on providing improved care for patients with systemic autoimmune disease. By supporting patient stratification and identifying treatment responders based on each patient’s unique molecular profile, ImmuType™ can improve the success rate, while reducing time and cost of clinical trials. Beyond enrollment, ImmuType™ can […]

Celdara Medical Receives $1.7M SBIR to Advance Treatment of Ovarian Clear Cell And Renal Cell Carcinomas

September 13, 2021 Celdara Medical

Celdara Medical, LLC today announced that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded a three-year Small Business Innovation Research (SBIR) Fast-Track award to fund the company’s advancement of CM-CX1, a chimeric antigen receptor (CAR) T cell therapy for the treatment of ovarian clear […]

The Fanger Center, an Innovative Collaboration with Celdara Medical and the New Hampshire Academy of Science, Opens at Crossroads Academy

August 26, 2021 Celdara Medical

Supported by Celdara Medical and named after its co-founder, the new building and STEM lab is designed for authentic, experiential learning and serves as an exemplary partnership for the future of STEM education LEBANON, N.H. – August 26, 2021 — Celdara Medical, LLC (Celdara), The New Hampshire Academy of Science […]

Pandemic Security Initiative Expands Scientific Advisory Board by Tapping Tulane Expert

August 11, 2021 Celdara Medical

Celdara Medical, LLC (“Celdara”) announced today the addition of Antonito T. Panganiban, Ph.D., to the Pandemic Security Initiative’s Scientific Advisory Board (SAB), a group of outstanding scientists and infectious disease experts who will advise the Pandemic Security Initiative as it seeks to protect the nation from future pandemics. The SAB […]

Celdara Medical and Global Virus Network Announce Collaboration to Advance Infectious Disease and Viral Infection Research and Development

June 3, 2021 Celdara Medical

BALTIMORE and CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, June 2, 2021 /PRNewswire/ — Celdara Medical, LLC (Celdara), an experienced biopharma developer focused on launching promising products for the patients who need them most, today announced a new strategic collaboration with the Global Virus Network (GVN), a coalition comprised of human and animal virologists from 63 Centers of Excellence […]

Celdara Medical and the University of Vermont Secure NIH Funding to Improve Pandemic Preparedness and Response

January 19, 2021 Celdara Medical

CAMBRIDGE, Mass. and LEBANON, N.H. and NEW YORK, Jan. 19, 2021 /PRNewswire/ — Celdara Medical, LLC (“Celdara”) today announced that the National Institute of Allergy and Infectious Disease (NIAID) of the National Institutes of Health (NIH) has awarded it a two-year Small Business Technology Transfer Research (STTR) grant to fund the development of a novel, broad-spectrum therapeutic/prophylactic […]

Celdara Medical Appoints Lauren Brunswick as General Counsel

January 4, 2021 Celdara Medical

Celdara Medical, LLC is pleased to announce the recent hiring of Lauren Brunswick, JD, who will join the Celdara team as General Counsel. Lauren will lead Celdara’s legal function, providing support for Celdara’s strategy, risk management, operations, and portfolio management processes. Lauren remarked, “I am thrilled to join the exceptionally […]